Your browser doesn't support javascript.
loading
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Pidala, Joseph; Hamadani, Mehdi; Dawson, Peter; Martens, Michael; Alousi, Amin M; Jagasia, Madan; Efebera, Yvonne A; Chhabra, Saurabh; Pusic, Iskra; Holtan, Shernan G; Ferrara, James L M; Levine, John E; Mielcarek, Marco; Anasetti, Claudio; Antin, Joseph H; Bolaños-Meade, Javier; Howard, Alan; Logan, Brent R; Leifer, Eric S; Pritchard, Theresa S; Horowitz, Mary M; MacMillan, Margaret L.
Afiliação
  • Pidala J; Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Hamadani M; BMT and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI.
  • Dawson P; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
  • Martens M; Emmes Corporation, Rockville, MD.
  • Alousi AM; Emmes Corporation, Rockville, MD.
  • Jagasia M; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Efebera YA; Division of Hematology/Oncology, Stem Cell Transplantation, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Chhabra S; Blood and Marrow Transplantation Program, The Ohio State University, Columbus, OH.
  • Pusic I; BMT and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI.
  • Holtan SG; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
  • Ferrara JLM; Medical Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO.
  • Levine JE; Blood and Marrow Transplant Program, Departments of Pediatrics and Medicine, University of Minnesota Medical School, Minneapolis, MN.
  • Mielcarek M; Blood and Marrow Transplantation Program, The Icahn School of Medicine at Mount Sinai, New York, NY.
  • Anasetti C; Blood and Marrow Transplantation Program, The Icahn School of Medicine at Mount Sinai, New York, NY.
  • Antin JH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Bolaños-Meade J; Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Howard A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Logan BR; Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and.
  • Leifer ES; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
  • Pritchard TS; BMT and Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI.
  • Horowitz MM; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD.
  • MacMillan ML; Emmes Corporation, Rockville, MD.
Blood ; 135(2): 97-107, 2020 01 09.
Article em En | MEDLINE | ID: mdl-31738834
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prednisona / Sirolimo / Doença Enxerto-Hospedeiro / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prednisona / Sirolimo / Doença Enxerto-Hospedeiro / Antibióticos Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article